These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28055283)

  • 21. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.
    Liu Y; Tan N; Zhou YL; Chen YY; Chen JY; Chen J; Luo JF
    J Nephrol; 2012; 25(3):332-40. PubMed ID: 21928234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of C-reactive protein and myocardial perfusion in patients with ST-elevation acute myocardial infarction.
    Hoffmann R; Suliman H; Haager P; Christott P; Lepper W; Radke PW; Ortlepp J; Blindt R; Hanrath P; Weber C
    Atherosclerosis; 2006 May; 186(1):177-83. PubMed ID: 16140308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.
    Di Stefano R; Di Bello V; Barsotti MC; Grigoratos C; Armani C; Dell'Omodarme M; Carpi A; Balbarini A
    Biomed Pharmacother; 2009 Dec; 63(10):773-80. PubMed ID: 19906505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction.
    Smit JJ; Ottervanger JP; Slingerland RJ; Kolkman JJ; Suryapranata H; Hoorntje JC; Dambrink JH; Gosselink AT; de Boer MJ; Zijlstra F; van 't Hof AW;
    Am J Cardiol; 2008 Feb; 101(4):446-51. PubMed ID: 18312755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (ST elevation myocardial infarction, non-ST elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures.
    García-García C; Subirana I; Sala J; Bruguera J; Sanz G; Valle V; Arós F; Fiol M; Molina L; Serra J; Marrugat J; Elosua R
    Am J Cardiol; 2011 Oct; 108(8):1061-7. PubMed ID: 21791326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction.
    Foussas SG; Zairis MN; Makrygiannis SS; Manousakis SJ; Anastassiadis FA; Apostolatos CS; Patsourakos NG; Glyptis MP; Papadopoulos JK; Xenos DC; Adamopoulou EN; Olympios CD; Argyrakis SK
    Heart; 2007 Aug; 93(8):952-6. PubMed ID: 17344331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
    Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower admission hemoglobin levels are associated with longer symptom duration in acute ST-elevation myocardial infarction.
    Shacham Y; Leshem-Rubinow E; Ben-Assa E; Roth A; Steinvil A
    Clin Cardiol; 2014 Feb; 37(2):73-7. PubMed ID: 24122930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of pre-admission statin therapy and the inflammatory response in ST elevation myocardial infarction patients.
    Rozenbaum Z; Ravid D; Margolis G; Khoury S; Kaufman N; Keren G; Milwidsky A; Shacham Y
    Biomarkers; 2019 Feb; 24(1):17-22. PubMed ID: 29620476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative evaluation of C-reactive protein as a short-term prognostic marker in severe unstable angina--a preliminary study.
    Bhagat S; Gaiha M; Sharma VK; Anuradha S
    J Assoc Physicians India; 2003 Apr; 51():349-54. PubMed ID: 12723647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [CYTOKINE PROFILE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH AND WITHOUT COMPLICATIONS].
    Aimagambetova AO; Karazhanova LK; Kotlyar A
    Klin Med (Mosk); 2017; 95(3):233-7. PubMed ID: 30303344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of preprocedure high-sensitivity C-reactive protein to predict death, recurrent myocardial infarction, and stent thrombosis according to stent type in patients with ST-segment elevation myocardial infarction randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention.
    Schoos MM; Kelbæk H; Kofoed KF; Køber L; Kløvgaard L; Helqvist S; Engstrøm T; Saunamäki K; Jørgensen E; Holmvang L; Clemmensen P
    Am J Cardiol; 2011 Jun; 107(11):1597-603. PubMed ID: 21439539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Predictive value of the markers of inflammation in acute coronary syndromes].
    Ben Khalfallah A; Sanaa I; Annabi N; Ousji M; Aloui H; Naffeti S
    Arch Mal Coeur Vaiss; 2005 Sep; 98(9):899-905. PubMed ID: 16231577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention.
    Lyngbæk S; Marott JL; Møller DV; Christiansen M; Iversen KK; Clemmensen PM; Eugen-Olsen J; Jeppesen JL; Hansen PR
    Am J Cardiol; 2012 Dec; 110(12):1756-63. PubMed ID: 22981263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of the early administration of pravastatin on C-reactive protein and interleukin-6 levels in the acute phase of myocardial infarction with ST segment elevation].
    Gonzálvez M; Ruiz Ros JA; Pérez-Paredes M; Lozano ML; Giménez DM; Martínez-Corbalán F; Carnero A; Cubero T; Gómez AE; Vicente V
    Rev Esp Cardiol; 2004 Oct; 57(10):916-23. PubMed ID: 15469788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of ST segment changes in lead aVR in patients with acute inferior myocardial infarction with ST segment elevation.
    Kukla P; Bryniarski L; Dudek D; Królikowski T; Kawecka Jaszcz K
    Kardiol Pol; 2012; 70(2):111-8. PubMed ID: 22427072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
    Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
    Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction.
    Sawant AC; Adhikari P; Narra SR; Srivatsa SS; Mills PK; Srivatsa SS
    Cardiol J; 2014; 21(5):500-8. PubMed ID: 24142685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.